Predicting pancreatic ductal adenocarcinoma using artificial intelligence analysis of pre-diagnostic computed tomography images.

Journal: Cancer biomarkers : section A of Disease markers
Published Date: Jan 1, 2022

Abstract

BACKGROUND: Early stage diagnosis of Pancreatic Ductal Adenocarcinoma (PDAC) is challenging due to the lack of specific diagnostic biomarkers. However, stratifying individuals at high risk of PDAC, followed by monitoring their health conditions on regular basis, has the potential to allow diagnosis at early stages.

Authors

  • Touseef Ahmad Qureshi
  • Srinivas Gaddam
    Gastroenterology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Ashley Max Wachsman
    Department of Radiology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Lixia Wang
    Department of Radiology, Chaoyang Hospital, Beijing, China.
  • Linda Azab
    Biomedical Imaging Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Vahid Asadpour
    Southern California Kaiser Permanente Medical Center, Los Angeles, CA, USA.
  • Wansu Chen
    Kaiser Permanente Southern California, Pasadena, CA, USA.
  • Yibin Xie
    Biomedical Imaging Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Bechien Wu
    Southern California Kaiser Permanente Medical Center, Los Angeles, CA, USA.
  • Stephen Jacob Pandol
    Gastroenterology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Debiao Li

Keywords

External Resources

Popular Topics
Recent Journals